MBX Biosciences, Inc. Common Stock – NASDAQ:MBX

MBX Biosciences, Inc. Common Stock stock price today

$13.58
-6.49
-32.34%

MBX Biosciences, Inc. Common Stock key metrics

Market Cap
 675.36M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

MBX Biosciences, Inc. Common Stock stock price history

MBX Biosciences, Inc. Common Stock stock forecast

MBX Biosciences, Inc. Common Stock financial statements

MBX Biosciences, Inc. Common Stock other data

Frequently Asked Questions (FAQ)

  • What's the price of MBX Biosciences, Inc. Common Stock stock today?

    One share of MBX Biosciences, Inc. Common Stock stock can currently be purchased for approximately $13.58.

  • When is MBX Biosciences, Inc. Common Stock's next earnings date?

    Unfortunately, MBX Biosciences, Inc. Common Stock's (MBX) next earnings date is currently unknown.

  • Does MBX Biosciences, Inc. Common Stock pay dividends?

    No, MBX Biosciences, Inc. Common Stock does not pay dividends.

  • How much money does MBX Biosciences, Inc. Common Stock make?

    MBX Biosciences, Inc. Common Stock has a market capitalization of 675.36M.

  • What is MBX Biosciences, Inc. Common Stock's stock symbol?

    MBX Biosciences, Inc. Common Stock is traded on the NASDAQ under the ticker symbol "MBX".

  • What is MBX Biosciences, Inc. Common Stock's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of MBX Biosciences, Inc. Common Stock?

    Shares of MBX Biosciences, Inc. Common Stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does MBX Biosciences, Inc. Common Stock have?

    MBX Biosciences, Inc. Common Stock employs 38 workers.

  • When MBX Biosciences, Inc. Common Stock went public?

    MBX Biosciences, Inc. Common Stock is publicly traded company for more then 25 years since IPO on 14 Jan 2000.

  • What is MBX Biosciences, Inc. Common Stock's official website?

    The official website for MBX Biosciences, Inc. Common Stock is mbxbio.com.

  • Where are MBX Biosciences, Inc. Common Stock's headquarters?

    MBX Biosciences, Inc. Common Stock is headquartered at 11711 N. Meridian Street, Carmel, IN.

  • How can i contact MBX Biosciences, Inc. Common Stock?

    MBX Biosciences, Inc. Common Stock's mailing address is 11711 N. Meridian Street, Carmel, IN and company can be reached via phone at +31 76590200.

MBX Biosciences, Inc. Common Stock company profile:

MBX Biosciences, Inc. Common Stock

mbxbio.com
Exchange:

NASDAQ

Full time employees:

38

Industry:

Biotechnology

Sector:

Healthcare

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

+31 76590200
11711 N. Meridian Street
Carmel, IN 46032

:
ISIN: US55287L1017
: